Impact of chronic infection with Chlamydia pneumoniae on incidence of cardiac allograft vasculopathy

Transplantation

Volumn 69, Issue 9, 2000, Pages 1962-1964

  Wittwer, Thorsten ^a   Pethig, Klaus ^b   Heublein, Bernd ^b   Teebken, Omke E ^b   Harringer, Wolfgang ^b   Haverich, Axel ^b   Wahlers, Thorsten ^a  

^a FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

^b HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ALLOGRAFT; ANGIOCARDIOGRAPHY; ARTICLE; CHLAMYDIASIS; CHLAMYDOPHILA PNEUMONIAE; CHRONIC DISEASE; CORONARY ARTERY DISEASE; FEMALE; GRAFT VERSUS HOST REACTION; HEART GRAFT; HEART VENTRICLE REMODELING; HUMAN; IMMUNOFLUORESCENCE; INCIDENCE; MAJOR CLINICAL STUDY; MALE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SEROCONVERSION; VASCULAR DISEASE;

EID: 0034658667     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-200005150-00040     Document Type: Article

References (11)

1. Pethig K, Heublein B, Wahlers T, Haverich A. Mechanism of luminal narrowing in cardiac allograft vasculopathy: inadequate vascular remodeling rather than intimai hyperplasia is the major predictor of coronary artery stenosis. Working Group on Cardiac Allograft Vasculopathy. Am Heart J 1998; 135 (4): 628.
2. Saikku P, Mattila K, Nieminen MS, et al. Serological evidence of an association of a novel Chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction. Lancet 1988; 2: 983.
3. Muhlestein JB, Anderson JL, Hammond EH, et al. Infection with Chlamydia pneumoniae accelerates the development of atherosclerosis and treatment with azithromycin prevents it in a rabbit model. Circulation 1998; 97: 633.
4. Wong YK, Gallagher PJ, Ward ME. Chlamydia pneumoniae and atherosclerosis. Herat 1999; 81: 232.
5. Gupta S. Chronic infection in the etiology of atherosclerosis -focus on Chlamydia pneumoniae. Atherosclerosis 1999; 143: 1.
6. Fang JC, Kinlay S, Kundsin R, Ganz P. Chlamydia pneumoniae infection is frequent but not associated with coronary arteriosclerosis in cardiac transplant recipients. Am J Cardiol 1998; 1479.
7. Miettinen H, Lehto S, Saikku P, Rönnemaa T, Pyöeälä K, Laakso M. Association of Chlamydia pneumoniae and acute coronary heart disease events in non-insulin dependent diabetic and non-diabetic subjects in Finland. Eur Heart J 1996; 17: 682.
8. Libby P, Egan D, Skarlatos S. Roles of infectious agents in atherosclerosis and restenosis: an assessment of the evidence and need for future research. Circulation 1997; 96: 4095.
9. Grattan M, Moreno-Cabral C, Starnes V, Oyer P, Stinson E, Shumway N. Cytomegalovirus infection is associated with cardiac allograft rejection and atherosclerosis. JAMA 1989; 261: 3561.
10. Grayston JT. Chlamydia pneumoniae, strain TWAR. Chest 1989; 95: 664.
11. Boman J, Soderberg S, Forsberg J, et al. High prevalence of Chlamydia pneumoniae DNA in peripheral blood mononuclear cells in patients with cardiovascular disease and in middle-aged blood donors. J Infect Dis 1998; 178: 274.